Syenex

Delivery vehicles and programmable payloads are critical components for all advanced therapies and are independent of a drug developer's core therapeutic insights. We provide best-in-class versions of these components to advanced therapy drug developers to accelerate the creation of new cures

We are excited to join the BioTools Innovator 2024 cohort! Looking forward to collaborating with other innovators building companies to accelerate the development of new medicines.

“Syenex’s mission is to create innovative, best-in-class delivery technologies that are universally accessible to enable the entire field of gene- and cell-therapy developers,” Joshua Leonard https://lnkd.in/gATDDWmt

See all of our current openings here: https://lnkd.in/gJT-kwP5

Excited to be growing our amazing team! Please reach out if you are interested in learning more about what we are building at Syenex and/or the Sr. RA Mol. Bio. position. 🧬🦠🧪

Congratulations to Devin Stranford, Joshua Leonard, et. al. on their latest publication in Nature Biomedical Engineering. The GEMINI platform makes complex delivery biology questions addressable with a fully DNA-based system. Ongoing exponential improvements in DNA synthesis and sequencing is defining this century of biology. At Syenex, we believe in the potential of platforms like GEMINI--applications that leverage DNA read/write technology--to enable the next generation of biotechnologies and therapeutics. https://lnkd.in/dmsC-yKB